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Background  
Aboriginal Australians experience a higher risk of diabetes than the general Australian population. In this 
paper, we conducted a nested case–control study to determine whether the presence of microalbuminuria 
and macroalbuminuria is associated with the development of diabetes among diabetes-free Aboriginal 
people at baseline. 
 
Methods  
Urine albumin to creatinine ratios (ACRs) were obtained from 882 Aboriginal people aged 20–74 years 
from one community. Among them 750 were free of either clinical known diabetes or newly diagnosed 
diabetes according to WHO 1999 criteria. Over an 11 year follow-up period, 117 participants developed 
diabetes. They were defined as cases. Each case was matched by an individual control with same sex and 
body mass index (BMI) category, and age within 2 years. Conditional logistic regression was used to assess 
the association between albuminuria and diabetes. 
 
Results 
 The baseline level of ACR was significantly higher among cases than among controls. The odds ratios for 
future diabetes were 2.36 [95% confidence interval (95% CI) 1.01–5.50] and 3.27 (95% CI 1.38–7.77) for 
middle and upper tertiles, respectively, with adjustment for age, BMI, serum total cholesterol, serum C-
reactive protein values, and fasting plasma glucose at the baseline. The adjusted odds ratios were 1.90 (95% 
CI 0.88–4.06) and 2.51 (95% CI 1.08–5.87) for those with microalbuminuria and macroalbuminuria, 
respectively. 
 
Conclusions  
The presence of microalbuminuria and macroalbuminuria predicts diabetes independent of other known 
risk markers of development of type 2 diabetes in Aboriginal people. 
 
Keywords : diabetes in minorities; albuminuria; case-control; Aboriginal health; epidemiology 
 
 
Aboriginal Australians have a higher prevalence of diabetes than the general Australian population.1 
Physical inactivity and obesity are independent predictors of type 2 diabetes.2 However, current physical 
inactivity and obesity may not fully explain the high risk of type 2 diabetes in Aboriginal people. There has 
been considerable focus on the concept of microalbuminuria, not only because it predicts renal disease in 
diabetes but also because it relates to premature mortality in the diabetic and in the general population. 
Albuminuria in Aboriginal people is a major risk factor for renal disease3 and cardiovascular disease. 4 
Albuminuria can also be present at the time of diagnosis of diabetes. An increased prevalence of 
microalbuminuria has been observed among those with impaired fasting glucose before developing 
clinically diagnosed diabetes. 5 Mykkanen et al. 6 reported microalbuminuria predicted the development of 
diabetes independently of blood pressure level. Brantsman et al. 7 hypothesized that the presence of 
increased urine albumin excretion in the non-diabetic population is associated with an increased risk of 
development of type 2 diabetes. Their 4 year follow-up data suggest that urinary albumin excretion is an 
independent predictor of diabetes. 7 However, their data were mainly from a Caucasian population in The 
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Netherlands. Their findings need to be confirmed in other populations. Confounding is a major concern in 
most observational studies. People with diabetes have significantly higher levels of most risk factors such 
as body mass index (BMI), waist circumference, glucose, and lipids than those without diabetes. In this 
study, we examine the association between albuminuria and type 2 diabetes in an Aboriginal population 
using an individually matched nested case-control study design. 
 
Subjects, materials, and methods 
In 1992 a community-wide renal disease screening programme was started in a remote Northern 
Territory Aboriginal community in Australia. Participants were offered a baseline examination and 
testing between 1992 and 1995. Eight hundred and eight two (882) adults aged 20–74 years were 
followed until April 30, 2005. 
During the baseline visit, a fasting venous blood sample was drawn for plasma glucose, and serum 
total cholesterol and triglycerides measurements. For those free from diabetes at baseline, plasma 
glucose levels were also measured 2 h after a 75 g oral glucose challenge. An individual with a 2 h 
plasma glucose level of 7.8–11.0 mmol/l was considered as having impaired glucose tolerance (IGT). 
Urinary albumin concentration was measured by the Beckman immunoassay. A urine albumin to 
creatinine ratio (ACR) was calculated (mg/mmol). Previous studies in Aboriginal people used 3.4 and 34 
mg/mmol as cut-off for microalbuminuria and macro (or overt) albuminuria.8–10 However, to be consistent 
with recent studies, this study defined normoalbuminuria as a urine ACR ,2.5 mg/mmol, microalbuminuria 
as a urine ACR 2.5–25 mg/mmol, and macroalbuminuria as a urine ACR .25 mg/mmol.11–13 In addition, 
baseline urine ACR values were categorized into tertiles based on the sex-specific distribution of the total 
study population. 
High sensitivity C-reactive protein concentrations were measured using the immunoturbidimetric C-
reactive protein assay on a Hitachi 917 analyser (Roche Diagnostics Australia) with a detection limit of 
0.03 mg/l. The assay’s analytical range was from 0.1 to 20 mg/l. Samples with values . 2 0  mg/l were 
measured using dilution techniques. The imprecision of the assay is , 5 % .  Other risk factors were 
measured, such as blood pressures, serum cholesterol, triglycerides, BMI, cigarette smoking, alcohol 
drinking, and the presence of diabetes, and have been described elsewhere.14–16 
A total of 132 participants who either had known diabetes before the baseline examination or were 
newly diagnosed as having diabetes at the baseline examination according to the World Health 
Organisation (WHO) 1999 criteria17 on fasting and 2 h post-load glucose values were excluded. 
During a median 11 year follow-up period, newly diagnosed cases of diabetes were determined 
through clinical and hospital records among 750 participants free from diabetes at baseline. A total of 
117 participants developed clinically diagnosed diabetes according to their symptoms, fasting and/or 2 
h post-load glucose values. Each case was matched by a control of the same sex and BMI category of 
< 2 5 ,  25–29, and > 3 0  kg/m2 and the closest age (within 2 years). Participants who died or had 
cardiovascular disease during the follow-up period before the diagnosis of diabetes were also 
excluded. 
The project was approved by the Joint Institutional Ethics Committee of the Menzies School of 
Health Research and Territory Health Services and The Behavioural and Social Science Ethical 
Review Committee of the University of Queensland. 
 
Statistical analysis 
We used a matched t-test to assess differences in means and the McNemar test to assess for differences 
in proportions. Since the urine ACR, plasma glucose, and C-reactive protein values were skewed, the 
logarithmic transformed values were used and their geometric means were presented. Conditional 
logistic regression was used to examine the association between diabetes and urine ACR values. Crude 
and adjusted odds ratios and their 95% confidence intervals (95% CIs) were calculated with the lowest 
urine ACR group as reference. Since each case was matched by a control with the same sex, sex cannot 
be a possible confounder. However, the potential residual confounding effects of age and BMI were 
further assessed in the multiple conditional logistic regressions along with other non-matched 
variables such as serum cholesterol, C-reactive protein, fasting plasma glucose, and impaired plasma 
glucose status. Interactions between ACR and other variables were tested. We also used a logarithmic 
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transformation of ACR as a continuous variable to assess its association with diabetes and its 
interactions with other factors as conducted in one of previous studies.7 All analyses were performed 
using Stata 9.0.18 
 
Results 
Baseline characteristics of study participants who were subsequently diagnosed with diabetes (cases) 
and those remaining free from diabetes (controls) are shown in Table 1. Since sex, age, and BMI are 
matching variables, as expected for successful matching, cases and controls are similar in those 
variables. Cases had higher serum cholesterol, plasma glucose, and C-reactive protein levels, and a 
higher proportion of participants with IGT than controls. There were no statistically significant 
differences in blood pressures, triglycerides, smoking and drinking, and waist circumferences. 
 
TABLE 1. Baseline characteristics of new diabetes cases and controls 
Variable Controls Cases P-value 
Number 117 117  
Age, yearsa 36.1 (10.3) 36.4 (10.4) 0.80 
BMI, kg/m2 a 26.2 (5.7) 26.7 (5.4) 0.46 
Waist circ. cma 94.7 (13.8) 95.9 (12.4) 0.48 
Systolic pressure, mm Hga 123.4 (16.8) 123.1 (19.5) 0.91 
Diastolic pressure, mm Hga 76.5 (12.2) 77.3 (13.8) 0.63 
Total cholesterol, mmol/la 4.7 (1.0) 5.0 (1.2) 0.08 
Triglycerides, mmol/lb 2.1 (1.8–2.4) 2.0 (1.8–2.2) 0.40 
CRP, mg/dlb 5.9 (4.8–7.2) 8.0 (6.6–9.6) 0.031 
Urine ACR, mg/mmolb 4.8 (3.3–7.0) 11.0 (7.8–15.6) 0.0014 
Fasting plasma glucose, mmol/lb 4.9 (4.7–5.1) 5.7 (5.3–6.1) 0.0003 
2 hr post-load glucose, mmol/lb 6.0 (5.7–6.4) 6.7 (6.2–7.3) 0.025 
Male (%)c 44 (37.6) 44 (37.6) 1 
Smoking(%)c 78 (66.7) 85 (72.6) 0.32 
Drinking(%)c 71 (60.7) 65 (55.6) 0.43 
Impaired glucose tolerance (%)c 10 (8.5) 25 (21.4) 0.0060 
a Mean (standard deviation). 
b Geometric means (95% CI). 
c Number (%). 
 
The geometric means of urine ACR was significantly higher among cases than among controls. Table 
2 shows higher proportions of microalbuminuria, macroalbuminuria, and participants in higher tertile 
groups among cases than among controls. 
In age, sex, and BMI matched analysis, the odds ratios of incident diabetes were 2.22 (95% CI 1.11–
4.48) and 3.32 (95% CI 1.61–6.85) for middle and upper tertiles, respectively, with the lower tertile 
group as reference. Similarly, odds ratios for microalbuminuria and macroalbuminuria were 2.22 (95% 
CI 1.15–4.29) and 2.69 (95% CI 1.30–5.56), respectively, relative to the normal albuminuria group. 
Interactions between albuminuria and other variables were examined and no significant interaction 
terms were observed. Adjusting for age and BMI had little impact on the effect estimate, as both were 
matching variables. Even after adjusting for possible confounding factors collected in this study, the 
associations between diabetes and elevated levels of ACR remained statistically significant. The 
adjusted odds ratios were 2.36 (95% CI 1.01–5.50) and 3.27 (95% CI 1.38–7.77) for middle and upper 
tertiles, and 1.90 (95% CI 0.88–4.06) and 2.51 (95% CI 1.08–5.87) for microalbuminuria and 
macroalbuminuria groups, respectively. Crude and adjusted odds ratios for log (ACR) as a continuous 
variable were significantly higher than the null effect. 
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TABLE 2. ACR Distribution among controls and cases 
 
 Controls      Cases    P-value 
ACR tertiles 
Lower 44 (37.6%) 22 (18.8%) 
 
Middle 32 (27.4%) 35 (29.9%)  
Upper 41 (35.0%) 60 (51.3%) 0.004 
Albuminuria 
Normal 53 (45.3%) 32 (27.4%) 
 
Microalbuminuria 33 (28.2%) 42 (35.9%)  
Macroalbuminuria 31 (26.5%) 43 (36.8%) 0.017 
 
Discussion 
In this matched nested case-control study, we found that an elevated urine ACR value is associated 
with the development of diabetes in Aboriginal people. This association is independent of age, sex, 
BMI, serum cholesterol, C-reactive protein, and fasting plasma glucose. Our findings suggest that 
albuminuria can precede and predict the development of diabetes in Aboriginal people. 
Albuminuria has usually been considered a consequence of diabetes.19 It has been associated with 
increased cardiovascular risk in populations with and without diabetes.13,20–22 In Aboriginal people, 
albuminuria predicts the risk of coronary heart disease independent of traditional risk factors.4 Several 
studies have demonstrated that microalbuminuria occurs in individuals without diabetes.19,23 
TABLE 3. Crude and adjusted odds ratios of diabetes according to baseline urine albumin 
/creatinine ratio values 
 
 ACR tertile vs lower   Albuminuria vs 
normal 
  
  Middle  Upper     Micro Macro Log10 (ACR) 
Crude OR 2.22 (1.11–4.48) 3.32 (1.61–6.85) 2.22 (1.15–4.29) 2.69 (1.30–5.56) 1.81 (1.26–2.58)
Adjusted OR 1 2.07 (1.00–4.29) 3.05 (1.44–6.46) 2.03 (1.02–4.03) 2.58 (1.21–5.49) 1.70 (1.18–2.45)
Adjusted OR 2 2.38 (1.11–5.09) 3.12 (1.45–6.69) 2.15 (1.06–4.35) 2.51 (1.17–5.38) 1.66 (1.15–2.40)
Adjusted OR 3 2.53 (1.11–5.79) 3.50 (1.51–8.09) 2.20 (1.04–4.65) 2.87 (1.25–6.56) 1.81 (1.20–2.72)
Adjusted OR 4 2.65 (1.13–6.22) 3.12 (1.32–7.38) 2.17 (1.02–4.60) 2.45 (1.04–5.76) 1.71 (1.12–2.59)
Adjusted OR 5 2.36 (1.01–5.50) 3.27 (1.38–7.77) 1.90 (0.88–4.06) 2.51 (1.08–5.87) 1.71 (1.13–2.59)
OR 1: Adjusted for age and BMI; OR 2: Adjusted for age, BMI, and total cholesterol; OR 3: Adjusted for 
age, BMI, total cholesterol, and CRP; OR 4: Adjusted for age, BMI, total cholesterol, CRP, and IGT; OR 5: 
Adjusted for age, BMI, total cholesterol, CRP, and fasting plasma glucose. 
 
Only two studies have examined whether it predicts the development of diabetes among people 
without diabetes.6,7 Both studies were conducted in Caucasian populations. Diabetes cases were 
determined during 4.2 years of follow-up in Brantsma et al.’s study7 and over 3.5 years in the study by 
Mykkanen et al.6 This nested case-control study is the first one in a high-risk indigenous population 
and has the longest follow-up of 11 years. 
The mechanism of the association is not clear. Confounding effects are a major concern for an 
observational epidemiological study. Albuminuria is associated with the insulin resistance and 
metabolic syndrome,23,24 and the presence of the metabolic syndrome and insulin resistance increases 
the risk of diabetes.25–27 In this study, we did not identify individuals with metabolic syndrome, but 
the major risk components of metabolic syndrome were adjusted for, either through the matched study 
design or multiple conditional logistic regressions. After such adjustment, the association between 
diabetes and albuminuria remained. Albuminuria and diabetes may also share other risk factors that 
are not currently known. Since the onset of type 2 diabetes is generally held to be at least several years 
before clinical diagnosis,28 the pathophysiology of diabetes related vascular complications probably 
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begins before the diagnosis of diabetes. Microalbuminuria is a marker of endothelial dysfunction, 
which may occur with early renal disease29 and before the current diagnosis of diabetes. 
Although the underlying mechanism of the association is still not clear, it is important to know that 
the presence of microalbuminuria and macroalbuminuria can precede diabetes and independently 
predict the risk of future diabetes. Improving kidney function may be potentially beneficial to 
preventing diabetes. Our results suggest that microalbuminuria and macroalbuminuria can at least be 
useful for identifying persons at increased risk of diabetes regardless of whether the association is 
causal. 
Our findings have particular clinical and public health implications for Aboriginal Australians since a 
high prevalence of albuminuria has also been found in many different Aboriginal communities.8,10,30 
We have already reported that, in this study population, > 30% of adults have microalbuminuria and 
20% have macroalbuminuria.4 
Our study had several limitations. First, the diabetes events were identified through hospital records 
and clinical records. It is likely that some undetected cases were included in the control group. The 
effect is likely to be underestimated owing to this bias. Second, those with albuminuria may be more 
likely to visit their doctors for other health problems. Therefore, the presence of diabetes among them 
is more likely to be identified. I f  this bias is present, it will overestimate the true association between 
albuminuria and diabetes, although there is no evidence on this. Third, albuminuria in this study was 
defined using random urine ACR values rather than 24 h urine collection for urinary albumin 
excretion. However, it has been found that spot ACR is a good screening test for microalbuminuria.31 
Fourth, because the study participants were Aboriginal adults from a remote community in the 
Northern Territory of Australia, the results may not be generalizable to other populations. The 
findings in the two Caucasian populations already cited, however, suggest otherwise. 
Branstma et al.  found that the predictive value of urine albumin excretion for diabetes was modified 
by the level of C-reactive protein. Urinary albumin excretion predicts the development of diabetes 
most strongly when the level of C-reactive protein is low.7 No significant interaction between C-
reactive protein and urine ACR was observed in our study. This may be due to a relatively small 
sample size. 
Compared with two previous s tudies , 6,7 this study used a different study design and different 
measuring method for albuminuria in a different population. However, the findings that the presence 
of microalbuminuria and macroalbuminuria predicts the future development of diabetes are consistent. 
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Key messages 
 The association between albuminuria and diabetes is independent of conventional risk factors for 
diabetes. 
 The presence of microalbuminuria and macroalbuminuria can precede diabetes and independently 
predict the risk of future diabetes. 
 Improving kidney function is potentially beneficial to preventing diabetes. 
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